Key facts
- This page summarizes Timothy Coughlin's Form 4 filing for aTYR PHARMA INC (ATYR).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 03 Jun 2024, 16:21.
Timothy Coughlin - 30 May 2024 Form 4 Insider Report for aTYR PHARMA INC (ATYR)
- Reporting relationship
- Director
- Issuer ticker
- ATYR
- Reported as of
- 30 May 2024
- Net transaction value
- +$87,500
- SEC form
- 4
- Accepted by SEC
- 03 Jun 2024, 16:21:12 UTC
- Prior SEC filing
- 23 May 2024
- Next SEC filing
- 11 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Nancy E. Denyes, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Timothy Coughlin filed Form 4 for aTYR PHARMA INC (ATYR) on 03 Jun 2024.
Change
- Previous filing in this sequence was filed on 23 May 2024.
- Current net transaction value: +$87,500.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LIFE
transaction
Common Stock
Purchase
- Transaction value
- $87,500
- Shares
- +50,000
- Change %
- +833%
- Price
- $1.75
- Shares after
- 56,000
- Date
- 30 May 2024
- Ownership
- See Footnote
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents weighted average price for the shares. The shares were purchased at prices ranging from $1.665 to $1.80 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
Footnote F2
These shares are owned by the Coughlin Family Trust u/a DTD 12/07/2006. The Reporting Person and his spouse serve as co-trustees of the Coughlin Family Trust u/a DTD 12/07/2006. The Reporting Person may be deemed to be the beneficial owner of the securities held by the Coughlin Family Trust u/a DTD 12/07/2006.